NMDA Receptor Function in Central Nervous System Disorders

NMDA receptors are ionotropic glutamate receptors that mediate excitatory neurotransmission and underpin synaptic plasticity, learning and memory. Their unique voltage-dependent block by magnesium and permeability to calcium endow them with a dual signalling role: they support pro-survival pathways at physiological activation levels while driving excitotoxic cascades under pathological overactivation. Aberrant NMDA receptor function is implicated in a spectrum of central nervous system disorders, including epilepsy, neurodevelopmental syndromes, schizophrenia and neurodegeneration. Gain-of-function mutations often enhance calcium influx and are associated with early-onset epileptic encephalopathies, whereas loss-of-function variants may disrupt synaptic maturation and contribute to intellectual disability or autism spectrum disorders. Dysregulated subunit composition—most notably of the GluN2A and GluN2B subunits—affects receptor kinetics, localisation and coupling to intracellular signalling complexes, thereby influencing susceptibility to excitotoxic injury and the balance between long-term potentiation and depression. Therapeutic strategies targeting NMDA receptor subtypes or allosteric sites seek to preserve physiological signalling while preventing pathological activation, offering promise for precision interventions across diverse neurological conditions.

Research from Nature Portfolio

Recent studies have revealed that NMDA receptor ion channel gating is orchestrated by two distinct molecular gates under subunit-specific control. One gate at the M3 helix bundle crossing governs the entry and exit from active clusters, primarily regulated by GluN2 subunits, while a second gate in the M2 loop modulates rapid openings within clusters under the influence of the GluN1 glycine residue. Molecular dynamics simulations and functional assays have confirmed that these gates operate semi-independently to shape the receptor’s characteristic burst kinetics, pointing to new opportunities for subunit-selective modulation of receptor activity in disease contexts.

NMDA Receptor Function in Central Nervous System Disorders publication trend

The graph below shows the total number of articles in nmda receptor function in central nervous system disorders across all publications each year (not limited to Nature Index journals).

Technical terms

Excitotoxicity: Neuronal injury and death resulting from excessive calcium influx through overactivated glutamate receptors.

Long-term potentiation (LTP): A sustained increase in synaptic strength following high-frequency stimulation, underlying memory formation.

Subunit composition: The specific assembly of NR1 and NR2 (e.g., GluN2A, GluN2B) proteins that determines NMDA receptor biophysical and pharmacological properties.

Allosteric modulation: Regulation of receptor activity by ligands binding to sites distinct from the agonist (glutamate) binding domain.

Chemogenetic inhibition: A method that uses engineered receptors and designer drugs to selectively suppress neuronal activity in defined cell populations.

References

1. Two gates mediate NMDA receptor activity and are under subunit-specific regulation. Nature Communications (2023).
2. Anterior cingulate cortex-related functional hyperconnectivity underlies sensory hypersensitivity in Grin2b-mutant mice. Molecular Psychiatry (2024).
3. GRIN2A-related disorders: genotype and functional consequence predict phenotype. Brain (2018).
4. Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology. PLOS Genetics (2017).